Sun BioPharma, Inc. Human Resources Contracts & Agreements
29 Contracts & Agreements
- Bonus & Incentive Agreements (5 contracts)
- Confidentiality Agreements (1)
- Consulting Agreements (2)
- Employment Agreements (18)
- Retention Agreements (3)
- Retention Agreement with Susan Horvath dated September 23, 2024 (Filed With SEC on September 27, 2024)
- Retention Agreement with Jennifer K. Simpson dated September 23, 2024 (Filed With SEC on September 27, 2024)
- Form of Retention Agreements dated February 7, 2024 (Filed With SEC on February 13, 2024)
- Dr. Suzanne Gagnon Consulting Agreement (Filed With SEC on March 24, 2022)
- Form of Employee Confidentiality and Intellectual Property Assignment Agreement with Company Officers (Filed With SEC on August 11, 2020)
- Employment Agreement with Jennifer K. Simpson, effective July 15, 2020 (Filed With SEC on July 16, 2020)
- Consulting Agreement with David Kaysen, dated October 31, 2018 (Filed With SEC on November 1, 2018)
- Employment Agreement with Susan Horvath, effective as of April 17, 2018 (Filed With SEC on May 14, 2018)
- Sun Biopharma, Inc. 2016 Omnibus Incentive Plan, amended and restated as of March 14, 2018 (Filed With SEC on March 20, 2018)
- Waiver and Third Amendment to Employment Agreement with Suzanne Gagnon, effective as of February 27, 2018 (Filed With SEC on March 5, 2018)
- Waiver and Third Amendment to Employment Agreement with Scott Kellen, effective as of February 27, 2018 (Filed With SEC on March 5, 2018)
- Waiver and Third Amendment to Employment Agreement with David B. Kaysen, effective as of February 27, 2018 (Filed With SEC on March 5, 2018)
- Waiver and Third Amendment to Employment Agreement with Michael T. Cullen, effective as of February 27, 2018 (Filed With SEC on March 5, 2018)
- Second Amendment to Employment Agreement with Suzanne Gagnon, effective as of October 1, 2017 (Filed With SEC on October 13, 2017)
- Second Amendment to Employment Agreement with Scott Kellen, effective as of October 1, 2017 (Filed With SEC on October 13, 2017)
- Second Amendment to Employment Agreement with David B. Kaysen, effective as of October 1, 2017 (Filed With SEC on October 13, 2017)
- Second Amendment to Employment Agreement with Michael T. Cullen, effective as of October 1, 2017 (Filed With SEC on October 13, 2017)
- SUN BIOPHARMA, INC. 2016 Omnibus Incentive Plan Performance-Based Stock Option Agreement (Filed With SEC on March 30, 2017)
- FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on September 16, 2016)
- FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on September 16, 2016)
- FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on September 16, 2016)
- FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on September 16, 2016)
- SUN BIOPHARMA, INC. 2016 Omnibus Incentive Plan Non-Qualified Stock Option Agreement (Filed With SEC on August 11, 2016)
- SUN BIOPHARMA, INC. 2016 Omnibus Incentive Plan Incentive Stock Option Agreement (Filed With SEC on August 11, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on December 4, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on December 4, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on December 4, 2015)
- INCENTIVE STOCK OPTION AGREEMENT OF SUN BIOPHARMA, INC. (with advance purchase rights) (Filed With SEC on September 11, 2015)
